Paige AI
FDA-cleared AI for prostate cancer pathology
- Always free
- No credit card
What is Paige AI?
Key features
FDA-cleared algorithm
Regulatory approval for clinical use in prostate cancer diagnosis
Histopathology image analysis
Processes microscopy slides to identify cancerous tissue patterns
Diagnostic support
Provides AI-assisted classification to help pathologists make decisions
Integration with lab workflows
Designed to work within existing pathology laboratory processes
Risk assessment
Helps categorise cancer aggressiveness and grade
Pros & cons
Advantages
- Regulatory approval means it meets clinical safety and accuracy standards
- Free to use, removing cost barriers for pathology labs
- Reduces diagnostic burden on pathologists by providing automated analysis
- Helps ensure consistency in cancer grading across different labs
- Supports better patient outcomes through improved diagnostic accuracy
Limitations
- Limited to prostate cancer pathology; not applicable to other cancer types
- Requires integration into existing lab infrastructure and workflows
- Results should be reviewed by qualified pathologists; AI is a tool, not a replacement
Use cases
Pathology labs reviewing prostate biopsy samples for cancer diagnosis
Hospital laboratory departments supporting oncology teams
Second opinion analysis on ambiguous or difficult prostate tissue samples
Training and quality assurance in pathology departments
Research institutions studying prostate cancer diagnosis patterns
Ready to try Paige AI?
Pricing
Get started with Paige AI
Click through to Paige AI and start using it now.
- Always free
- No credit card